Cancer clinical trials in the region Provence-Alpes-Côte d'Azur

154 currently recruiting clinical trials
Region Provence-Alpes-Côte d'Azur

Phase 2 Lymphoma
#NCT03960840
B cell lymphoma Lymphocytic lymphoma None Treated / Controled Targeted therapy 1 2 3 or more
Systemic Treatment-Naive Car-T Allogeneic stem cell transplant
7 main criterias to confirm
Institut Paoli-Calmettes (Marseille)
Novartis
Phase 2 Lymphoma
#NCT03960840
B cell lymphoma Large B cell lymphoma None Treated / Controled 2 3 or more
Systemic Treatment-Naive Car-T Allogeneic stem cell transplant
6 main criterias to confirm
Institut Paoli-Calmettes (Marseille)
Novartis
Phase 2 Lymphoma
#NCT05660967
B cell lymphoma Large B cell lymphoma CD20 None Systemic Treatment-Naive None
Autologous stem cell transplant Allogeneic stem cell transplant Car-T
8 main criterias to confirm
Hôpital de la Conception AP-HM (Marseille)
Genmab
Phase 2 Lymphoma
#NCT05463263
B cell lymphoma T cell lymphoma None 2 3 or more
Systemic Treatment-Naive
5 main criterias to confirm
Institut Paoli-Calmettes (Marseille)
Step Pharma, SAS
Phase 2 Lymphoma
#NCT05329792
T cell lymphoma Cutaneous T-cell lymphoma 1 2 3 or more
Systemic Treatment-Naive Systemic Treatment-Naive
6 main criterias to confirm
Hôpital de la Timone AP-HM (Marseille)
Philogène SpA
Phase 2 Lymphoma
#NCT04728893
B cell lymphoma Lymphocytic lymphoma None Treated / Controled 1 2 3 or more
Systemic Treatment-Naive
6 main criterias to confirm
Institut Paoli-Calmettes (Marseille), CHU Nice Hôpital l'Archet (Nice)
Merck Sharp & Dohme LLC
Phase 2 Lymphoma
#NCT04802590
B cell lymphoma Mantel cell lymphoma CD20 None > 60 ml/min 50-60 ml/min Systemic Treatment-Naive None
8 main criterias to confirm
Institut Paoli-Calmettes (Marseille), Centre Hospitalier d'Avignon (Avignon)
Organisation de recherche universitaire sur le lymphome
Phase 2 Lung cancer
#NCT04919811
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic ROS-1
4 main criterias to confirm
Hôpital Nord de Marseille (Marseille Cedex 20)
Thérapeutique AnHeart Inc
Phase 1 / Phase 2 Lung cancer
#NCT05650879
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced Metastatic HER2 Chemotherapy 1 2 3 or more
ALK BRAF EGFR ROS-1 Systemic Treatment-Naive
9 main criterias to confirm
Hôpital de la Timone AP-HM (Marseille)
Enliven Therapeutics
Phase 1 / Phase 2 Breast cancer
#NCT04143711
HER2 Negative HR Positive Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
6 main criterias to confirm
Institut Paoli-Calmettes (Marseille)
Dragonfly Therapeutics